Prolonged Release Evaluation of an Injectable Anticancer Drug using Human Serum Albumin Nanoparticle

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

REZAEI F.; SAEIDIFAR M.; JAVAHERI M.; SANGPOUR P.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BIOMACROMOLECULAR JOURNAL Year:2016 | Volume:2 | Issue:2 Page(s): 118-125

Download Full-Text

View:

157

Download:

106

Cites:

Information Journal Paper

Title

Prolonged Release Evaluation of an Injectable Anticancer Drug using Human Serum Albumin Nanoparticle

Author(s)

REZAEI F. | SAEIDIFAR M. | JAVAHERI M. | SANGPOUR P. | Issue Writer Certificate

Keywords

Prolonged release

Human serum albumin

Nanoparticles

Anticancer

Abstract

Human serum albumin Nanoparticles (HSA-NPs) were synthesized using the modified desolvation method. Fourier transform infrared spectroscopy (FT-IR), electronic absorption spectroscopy (UV-Vis), Zeta Sizer as well as field emission scanning electron microscope (FESEM) of the sample confirmed the formation of HSA NPs with an average size of 68 nm. The obtained results shown that HSA-NPs was successfully synthesized. The cytotoxic study of HSA-NPs in the HFFF2, normal cell lines was conducted and cell viability percentage demonstrated more than 90% within 24 h. Therefore, the synthesized NPs were nontoxic compared to the control samples. Furthermore, the release of the oxaliplatin as an Anticancer drug incorporated in HSA NPs was also investigated in physiological conditions. The drug loading (DL) and drug entrapment efficiency (DEE) were enhanced and the DL of 0. 9% and DEE of 51% are achievable. The Higuchi model was shown the best fitting compared to the different kinetically release model. This result and result of cyclic voltammetry indicated that the drug release mechanism followed by diffusion manner. Therefore, our present study showed that the biocompatible HSA NPs could improve Prolonged release of oxaliplatin as Anticancer drugs.

Cites

No record.

References

No record.

Cite

APA: Copy

REZAEI, F., SAEIDIFAR, M., JAVAHERI, M., & SANGPOUR, P.. (2016). Prolonged Release Evaluation of an Injectable Anticancer Drug using Human Serum Albumin Nanoparticle. BIOMACROMOLECULAR JOURNAL, 2(2), 118-125. SID. https://sid.ir/paper/348338/en

Vancouver: Copy

REZAEI F., SAEIDIFAR M., JAVAHERI M., SANGPOUR P.. Prolonged Release Evaluation of an Injectable Anticancer Drug using Human Serum Albumin Nanoparticle. BIOMACROMOLECULAR JOURNAL[Internet]. 2016;2(2):118-125. Available from: https://sid.ir/paper/348338/en

IEEE: Copy

F. REZAEI, M. SAEIDIFAR, M. JAVAHERI, and P. SANGPOUR, “Prolonged Release Evaluation of an Injectable Anticancer Drug using Human Serum Albumin Nanoparticle,” BIOMACROMOLECULAR JOURNAL, vol. 2, no. 2, pp. 118–125, 2016, [Online]. Available: https://sid.ir/paper/348338/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops